Dr. Melissa Barnett is a principal optometrist at the University of California, Davis Eye Center and is Past President of The Scleral Lens Education Society. Drs. Melissa Barnett and Lynette Johns authored and edited the book Contemporary Scleral Lenses: Theory and Application with the unique perspectives and contributions of international experts.
Scleral lenses were first conceptualized by Leonardo DaVinci in the early 16th century,1 and were the earliest type of contact lenses manufactured.2 Scleral lenses have evolved from glass and PMMA to gas permeable (GP) materials, 3-6 reducing the adverse physiological effects induced by the original scleral lens materials. The shortcomings of early designs included very poor oxygen transmissibility, which led to lens-induced corneal edema, later known as Fick’s phenomenon or Sattler’s veil, corneal hypoxia, and ultimately discontinuation of lens wear. Also, each lens was handcrafted and impossible to replicate if broken or lost. In recent years, improvements in manufacturing techniques and ocular imaging have led to a resurgence in scleral lens prescribing.7,8 There are numerous optical and therapeutic indications that may result in a patient being prescribed scleral lenses,9,10 the major ones being visual rehabilitation in irregular corneas, therapeutic treatment of ocular surface disease and correction of refractive error in normal or healthy eyes. Currently, 10% of all contact lenses fit globally are comprised of GP materials.11,12 The majority of these are corneal lenses (75%), followed by scleral (13%), orthokeratology (8%), and hybrid lenses (5%).11,12 The expanding scleral lens modality has been variously termed “the rigid lens renaissance: a surge in sclerals”,13 “scleral lenses are blooming”14 and “scleral GP lenses have come of age”.15 Additionally, the number of publications in the peer reviewed literature on this topic is rapidly increasing.16
Scleral lens practitioners carefully and systematically successfully manage patients who have challenging eyes, partially or completely restoring their vision, and often their functionality.16 Scleral lenses not only manage a condition, the technology treats the entire person, and even entire families.16
Fifteen years ago, only a handful of specialized practitioners were successfully fitting scleral lenses, and only a few laboratories were producing them.17 Today, multiple manufacturers are developing new and innovative scleral lens designs, solutions, and technologies. Thus, scleral lenses are becoming far more “mainstream” in contact lens practice.17 Studies have assessed the practitioner learning curve when fitting scleral lenses. With practitioner experience, both the number of trial lenses required to achieve the best fit and the number of reorders with time was reduced.18,19
Scleral Lenses Reduce the Need for Corneal Transplantation
Keratoconus is the most prevalent primary corneal ectasia, which commonly causes bilateral asymmetric thinning of the paracentral cornea.26 Due to its progressive nature, early diagnosis and management is critical. Corneal collagen cross-linking with prompt intervention can halt the progression of keratoconus. Scleral lenses should be considered for all patients with advanced corneal ectasia for visual rehabilitation and to neutralize irregularities of the corneal surface.27 Scleral lenses may reduce or delay the need for corneal transplantation, with the indication for keratoplasty being cited as one-fifth in a keratoconus population.28 Scleral lens fitting outcomes were compared to keratoplasty in a keratoconus population.27 In the scleral lens group, vision improved more rapidly, mean visual acuity was better after one year, and fewer complications were experienced compared to those who underwent keratoplasty. Ling et al. evaluated the influence of scleral lenses on the rate of corneal transplantation for keratoconus.28 In this study, a total of only 3.2% of eyes underwent keratoplasty. 28In a study by Koppen et al, the need for keratoplasty was reduced by more than half in a severe keratoconus population.29 Scleral lenses were used to successfully treat 40 of 51 eyes with severe keratoconus. In their practice population, the indication for corneal transplantation was 1.65%.29Scleral lenses should be considered for patients with keratoconus prior to surgical intervention for those who cannot successfully wear other modes of correction.
Scleral Lenses as OcularDrug Delivery Systems
The utilization of scleral lenses as drug delivery devices has been demonstrated.30 Scleral lenses have been reported as drug delivery systems to deliver antibiotics,31,32 anti-vascular endothelial growth factor (anti-VEGF) agents,33-35 and stem cells with compounded products.36 The large fluid reservoir provides a protected environment in which the corneal surface is continuously bathed in preservative-free fluid. These lenses are inherently stable to provide continuous ocular penetration of a drug. Scleral lenses exhibit minimal tear exchange after lens settling; tear exchange has been reported at 0.2% per minute of wear.37 If a topical drug is applied over a scleral lens, there is minimal accumulation in the post-lens fluid reservoir. Alternatively, drugs applied in the reservoir prior to lens application should remain for the majority of the scleral lens wearing time. The replenishment of fluid under a scleral lens requires more than 8 hours of lens wear. A study evaluated post-lens tear dynamics at two different time points, during and after scleral lens wear with post-lens tear fluorescence.38 Approximately one-third of the subjects had no tear flow into the post-lens fluid reservoir after 5 hours of lens wear.38 Scleral lenses may function as an ideal drug delivery system to provide a therapeutic level of drug at the desired target tissue, with minimal variability and have a duration appropriate for the therapeutic indication.30
Midday fogging
Post-lens tear reservoir debris (midday fogging) occurs when debris accumulates between the scleral lens and cornea, and may occur after minutes to hours of lens wear.39,40 Midday fogging requires frequent lens removal and reapplication, which is clearly an inconvenience for scleral lens wearers. The literature has demonstrated that post-lens tear debris consists of a high concentration of leukocytes,41 lipids,42 and external tear film debris.43 Complications related to tear reservoir clouding are especially common in those with ocular surface disease.44 There are numerous proposed causes of scleral lens fogging, including increased tear exchange and accumulation of tear debris in the lens reservoir, increased mucin production from rubbing of the conjunctival tissue, accumulation of protein and lipid deposits on the front surface of the lens (Figure 1) and corneal edema (Figure 2).45
Figure 1: Corneal edema in a patient with severe dry eye and neurotrophic keratitis.
Figure 2: Surface debris on a scleral lens
Fogging is typically associated with debris, either on the front surface of the lens or in the post-lens fluid reservoir. Symptoms of fogging are similar, despite the cause. Corneal edema should be ruled out immediately by removing, cleaning and reapplying the scleral lens. If a patient experiences rainbows around lights (Sattler’s veil) or vision continues to be blurred, evaluate the cornea for corneal edema. Midday fogging is diagnosed through biomicroscopy, OCT, or Scheimpflug imaging, rather than symptoms alone, since corneal edema or a non-wetting anterior lens surface can also cause visual symptoms during lens wear.
Factors associated with patient-reported midday fogging in established scleral lens wearers were evaluated.46 Midday fogging was self-reported in 64 patients of 248 survey respondents (25.8%). Midday fogging was not correlated with demographic characteristics (age, sex, race/ethnicity), scleral lens indications, mean lens diameter (P = .30), haptic design (P = .29), use of a daily cleaner (P = .12), disinfection/storage solution used (P = .71), or filling solution (P = .65). Associated redness or irritation were more frequently reported in patients who described midday fogging compared with those who did not experience the condition (P = .03). Elevated inflammatory mediators in the post-lens fluid reservoir of patients with midday fogging, or ocular redness or irritation associated with scleral lens wear suggests that ocular surface inflammation may be contributory.
A recent study investigated if midday fogging could be mitigated by a novel scleral lens filling solution, which closely approximates the ionic concentration and pH of human tears.47 This study is reviewed in the ‘Feature article’ section of this issue.
In Office Disinfection
In a scleral lens practice, both empirical fitting and diagnostic lens fitting with trial lenses can be effective. Historically, the use of diagnostic, or trial, contact lenses is customary. Practitioners commonly apply one or more lenses during a diagnostic fitting, which must be disinfected prior to storage and use on another patient to prevent transfer of potential pathogens. These pathogens may be introduced into the system from one patient to another or may be transferred by the practitioner or staff during handling and storage, or both. According to the new Guidelines for Handling of Multipatient Contact Lenses in the Clinical Setting, contact lenses are divided into three categories for disinfection purposes:48 Soft contact lenses (hydrogel and silicone hydrogels); GP lenses (corneal and scleral lenses); hybrid lenses (composite; composed of a GP center with a hydrogel periphery).
All contact lenses should be initially rubbed with a daily surfactant cleaner, which is used to remove particulate matter, deposits, and debris from contact lenses to ensure more effective disinfection. Next, diagnostic lenses are soaked in non-neutralized ophthalmic grade 3% hydrogen peroxide solution for a minimum of three hours.48 Finally, the lenses are neutralized by rinsing with sterile saline or multipurpose solution and then stored dry in a disinfected case. These steps are summarized in a downloadable reference factsheet found in the ‘Clinical insight’ section of this issue. In addition, the 2018 ISO Standards suggest documenting each contact lens disinfection and maintaining a record for each diagnostic fitting set. The record should include the reference number for each lens, the patient reference for each lens, date(s) of use, date(s) of disinfection, method of disinfection, and the person performing disinfection. This record could prove helpful in tracing any infection arising from use of that diagnostic lens.
The Future of Scleral Lenses
Since scleral lenses are rotationally stable with minimal movement with the blink, they are now being used as a stable platform for a range of optical applications. A reflecting telescopic system embedded within a scleral lens has been developed 49-51 that can alternate between unmagnified and 3x magnification in response to a controlled blink. This system has potential applications for the military (rapid hands free distance magnification) and low vision rehabilitation (Figure 3).
Figure 3. Scleral lens-based telescope. Image courtesy of Glenn Schuster.
A smart device is an electronic device that connects to other devices to support everyday human activities and connect, share, and interact with their users. Mojo Vision unveiled their smart scleral lens in January 2020. It incorporates a 480µm display, roughly the size of a grain of sand, comprising of 70,000 pixels supported by several micro-components, including a microprocessor and an image sensor52 (Figure 4). The display delivers a world-record pixel pitch of over 14,100ppi and a pixel density of over 200Mppi², making it the smallest, densest display ever designed for dynamic, or moving content. The lens draws its power from a tiny-solid state battery, which can be recharged in the lens case at the end of the day and will be paired with another device to send and receive data. This invisible computing device has many potential applications, including low vision rehabilitation and visual augmentation.53
Figure 4. Image of a smart scleral lens. Image courtesy of Mojo Vision.
The past decade of modern scleral lenses has demonstrated the amazing benefits of this technology. In parallel with the increase in utilization, scleral lens publications continue to increase each year. However, there are still numerous research questions to be answered. These include whether there is a potential increase in intraocular pressure with scleral lens wear, their physiological response when worn, questions around lens materials, application and disinfection solutions and a better understanding of ocular shape. Scleral lenses are a modality that offer numerous advantages and changes lives for the better and the future of scleral lenses is bright.
Educational resources
There are many useful resources available for scleral lens education. A book solely dedicated to scleral lenses titled ‘Contemporary Scleral Lenses: Theory and Application’ by Melissa Barnett and Lynette Johns (Bentham Science Publishers) is available in hardback, paperback and pdf versions.20,21
Scleral Lens Issues and Complications: Their Recognition, Etiology and Management by Daddi Fadel is available in print and e-book versions.22‘A Clinical Guide to Scleral Lens Success’ by Melissa Barnett and Daddi Fadel is a practical guide to scleral lens fitting, is available in English, Italian, Spanish, Russian and Portuguese and can be downloaded from the Scleral Success website.23 ‘A Guide to Scleral Lens Fitting Version 2.0’ updated in 2015 by Eef van der Worp can be downloaded from the Pacific University website.24 ‘Scleral Lens Fit Scales’ is a guide to estimating central and limbal clearance and the edge relationship.25 This guide is available in English and Spanish and can be downloaded from the Ferris State University website.25
A multitude of resources regarding scleral lenses can be found on the Scleral Lens Education Society (SLS) (sclerallens.org) and Gas Permeable Lens Institute (GPLI) (gpli.info) websites. A dedicated Facebook group ‘Scleral Lens Practitioners’ welcomes everyone with an interest in scleral lenses. Meetings such as the Global Specialty Lens Symposium (GSLS), The British Contact Lens Association (BCLA), The International Congress of Scleral Contacts (ICSC), The Nederlands Contactlens Congress (NCC) and the Cornea & Contact Lens Society of Australia (CCLSA) are events that regularly provide education for practitioners wishing to learn more about scleral lenses.
REFERENCES:
Ferrero N. Leonardo da Vinci: of the eye; an original new translation from Codex D. Am J Ophthalmol 1952;35;4: 507-521.
Bowden T. Contact Lenses: The Story. 2009, Gravesend, Kent: Bower House.
Ezekiel D. Gas permeable haptic lenses. J Br Contact Lens Assoc 1983:6(40):158-161
Rosenthal P. Clinincal performance and fitting principles of “rigid” super permeable contact lenses. J Br Contact Lens Assoc 1986;9:88–90.
Lyons CJ, Buckley RJ, Pullum K, Sapp N. Development of the gas‐permeable impression‐moulded scleral contact lens: A preliminary report. Acta Ophthalmol 1989;67:162–164.
Pullum KW. Feasibility study for the production of gas permeable scleral lenses using ocular impression techniques. J Br Contact Lens Assoc 1987;1987:35–39.
Vincent SJ. The rigid lens renaissance: A surge in sclerals. Contact Lens Anterior Eye 2018;41(2):139-143
Woods CA, Efron N, Morgan P. Are eye‐care practitioners fitting scleral contact lenses? Clin Exp Optom 2020;103(4):449-453
Schornack, M. Medical indications for scleral lens use in Barnett M, Johns LK. Contemporary Scleral Lenses: Theory and Application. Bentham Science 2017. Chapter 5 132-166. Volume 4 ISBN: 978-1-68108-567-8.
Fadel D, Kramer E. Potential contraindications to scleral lens wear. Contact Lens Anterior Eye 2019;42(1):92-103
Efron N, Morgan PB, Woods CA; International Contact Lens Prescribing Survey Consortium. International survey of rigid contact lens fitting. Optom Vis Sci. 2013;90(2):113-118.
Vincent SJ. The rigid lens renaissance: A surge in sclerals. Contact Lens & Ant Eye. 2018;41:139-143.
van der Worp E. Scleral lenses (are) special. Contact Lens Anterior Eye, 2017: 40, 271-2.
Bergmanson JPG, Barnett M, Naroo SA. Scleral gas permeable lenses have come of age. Contact Lens Anterior Eye. 2016:39:247–8.
van der Worp E, Johns L, Barnett M. Scleral Lens Special Edition in Contact Lens Anterior Eye. Guest Editor. 2019;42(1):1-128
Barnett M. Building a Scleral Lens Practice. Contact Lens Spectrum. 2017;32:4-6,8.
Bauer A, Scleral Lens Data: The first 150 fits. Free Paper presented at Global Specialty Lens Symposium (GSLS), Las Vegas, Nevada, USA, 2018.
Macedo-de-Araújo, RJ, van der Worp, E, González-Méijome JM. Practitioner Learning Curve in Fitting Scleral Lenses in Irregular and Regular Corneas Using a Fitting Trial. BioMed Research International 2019;2019:1-11 https://doi.org/10.1155/2019/5737124
Barnett M, Johns LK. Contemporary Scleral Lenses: Theory and Application. Bentham Science 2017. Volume 4 ISBN: 978-1-68108-567-8 (Print); 978-1-68108-566-1 (Online). DOI:10.2174/97816810856611170401
Van der Worp E. A Guide to Scleral Lens Fitting v 2.0 A.f. http://commons.pacificu.edu/mono/10/. Editor. Forest Grove, Oregon, Pacific University. 2015
Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol 1984; 28(4): 293-322.
Deloss KS, Fatteh NH, Hood CT. Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral device compared to keratoplasty for the treatment of corneal ectasia. Am J Ophthalmol 2014;158(5):974-82
Ling JJ, Mian SI, Stein JD, Rahman M, Poliskey J, Woodward MA. Impact of Scleral Contact Lens Use on the Rate of Corneal Transplantation for Keratoconus. Cornea. 2020. May 2020 Published ahead of print: https://doi.org/10.1097/ICO.0000000000002388.
Koppen C, Kreps EO, Anthonissen L, Van Hoey M, Dhubhghaill SN, Vermeulen L. Scleral Lenses Reduce the Need for Corneal Transplants in Severe Keratoconus. Am J Ophthalmol 2018;185:43-47.
Novack GD, Barnett M. Ocular Drug Delivery Systems Using Contact Lenses. J Ocul Pharmacol Ther. 2020;36(8):595-601.
Kalwerisky, K., Davies, B., Mihora, L., Czyz, C.N., Foster,J.A., and DeMartelaere, S. Use of the Boston Ocular Surface Prosthesis in the management of severe periorbital thermal injuries: a case series of 10 patients. Ophthalmology. 2012;119:516–521.
Ciralsky, J.B., Chapman, K.O., Rosenblatt, M.I., et al. Treatment of refractory persistent corneal epithelial defects: a standardized approach using continuous wear PROSE therapy. Ocul Immunol Inflamm. 2015;23:219–224.
Keating, A.M., and Jacobs, D.S. Anti-VEGF treatment of corneal neovascularization. Ocul Surf 2011;9:227–237.
Lim, M., Jacobs, D.S., Rosenthal, P., and Carrasquillo,K.G. The Boston Ocular Surface Prosthesis as a novel drug delivery system for bevacizumab. Semin Ophthalmol 2009;24:149–155.
Yin, J., and Jacobs, D.S. Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization. Ocul. Surf. 2019;17:134–141.
Espandar, L., Caldwell, D., Watson, R., Blanco-Mezquita,T., Zhang, S., and Bunnell, B. Application of adipose derived stem cells on scleral contact lens carrier in an animal model of severe acute alkaline burn. Eye Contact Lens. 2014;40:243–247.
Vance, K., Miller, W., and Bermangson, J. Measurement of tear flow in scleral contact lens wearers. The 94th American Academy of Optometry. New Orleans, LA; 2015.
Tse, V., Tan, B., Kim, Y.H., Zhou, Y., and Lin, M.C. Teardynamics under scleral lenses. Contact Lens Anterior Eye. 2019;42:43–48.
McKinney A, Miller W, Leach N, Polizzi C, van der Worp E, Bergmanson J. The Cause of Midday Visual Fogging in Scleral Gas Permeable Lens Wearers. Invest Ophthalmol Vis Sci 2013:ARVO E–Abstract 5483.
Postnikoff CK, Pucker AD, Laurent J, Huisingh C, McGwin G, Nichols JJ. Identification of leukocytes associated with midday fogging in the post-lens tear film of scleral contact lens wearers. Investig Ophthalmol Vis Sci 2019;60(1):226-233.
Walker MK. Laboratory Analysis of Scleral Lens Tear Reservoir Clouding. Global Specialty Lens Symposium, Las Vegas Jan 2014.
Walker MK, Bergmanson JP, Miller WL, Marsack JD, Johnson LA. Complications and fitting challenges associated with scleral contact lenses: A review. Contact Lens Anterior Eye 2016; 39(2):88-96
Walker M, Morrison S, Caroline P, et al. Laboratory analysis of scleral lens tear reservoir clouding. Poster presented at the 2014 Global Specialty Lens Symposium, Las Vegas, Jan 2014.
Carrasquillo, KG, Lipson MJ, Ezekiel DJ, et al. Chapter 12 Scleral Lens Complications and Problem Solving in Barnett M, Johns LK. Contemporary scleral lenses: theory and application. United Arab Emirates: Bentham Science Publishers, 2017. Pages 395-404.
Schornack MM, Fogt J, Harthan J, et al. Factors associated with patient-reported midday fogging in established scleral lens wearers. Cont Lens Anterior Eye. 2020 Mar 20. pii: S1367-0484(20)30048-5. doi: 10.1016/j.clae.2020.03.005. [Epub ahead of print]
Fogt JS, Karres M, Barr JT. Changes in Symptoms of Midday Fogging with a Novel Scleral Contact Lens Filling Solution. Optom Vis Sci. 2020; published online ahead of print: doi: https://doi.org/10.1016/j.clae.2020.03.005
Sindt C, Bennett E, Szczotka-Flynn L, Sclafani L, Barnett M; American Academy of Optometry (AAO) Section on Cornea, Contact Lenses & Refractive Technologies, and The American Optometric Association (AOA) Contact Lens and Cornea Section. Technical Report: Guidelines for Handling of Multipatient Contact Lenses in the Clinical Setting. Optom Vis Sci. 2020;97(8):544-548.
Arianpour A, Schuster GM, Tremblay EJ, Stamenov I, Groisman A, Legerton J, et al. Wearable telescopic contact lens. Appl Opt 2015;54(24):7195-7204.
Schuster GM, Arianpour A, Cookson S, Zhang A, Hendrik L, O’Brien T, et al. Wink-controlled polarization-switched telescopic contact lenses. Appl Opt 2015;54:9597–9605.
Tremblay EJ, Stamenov I, Beer RD, Arianpour A, Ford JE. Switchable telescopic contact lens. Opt Express 2013;21(13): 15980-15986.
Tran K, Lum R, Bauer M, Sindt C, Tuan A. Characterization of impression-based scleral lens movement during wear. Invest Ophthalmol Vis Sci 2020;61:1478.